Over Four Million Ghanaians Living With Viral Hepatitis as Ghana Steps Up 2030 Elimination Drive

More than four million Ghanaians are estimated to be living with viral hepatitis, highlighting the scale of a major public health challenge that often progresses unnoticed until serious liver damage occurs.

Hepatitis B and C remain the two major forms of viral hepatitis of public health concern in Ghana. Both can cause chronic liver disease, cirrhosis, liver failure and liver cancer when infections are not detected and properly managed.

Ghana has established a national hepatitis control programme to coordinate the country's response, including prevention, testing, treatment, surveillance, public education and efforts towards meeting the World Health Organisation's target of eliminating viral hepatitis as a public health threat by 2030.

Available studies have estimated that millions of Ghanaians have been exposed to or are living with Hepatitis B and C, although prevalence estimates vary considerably depending on the population, geographical area and methodology used.

The burden is particularly concerning in parts of northern Ghana. Studies have reported relatively high rates of Hepatitis B in the Savannah, Northern, Upper East and Upper West Regions, while some research has also identified significant pockets of Hepatitis C infection in northern communities.

The consequences can be devastating. Chronic viral hepatitis may remain without obvious symptoms for years, earning it a reputation as a “silent epidemic.” By the time some patients seek medical attention, they may already have developed advanced liver disease.

The challenge extends beyond medicine. Lack of awareness, misconceptions about the causes of hepatitis, stigma, treatment costs and difficulties accessing specialised services can prevent people from being tested or seeking care early.

Hepatitis B can be transmitted through infected blood and other body fluids, including through unprotected sexual contact, unsafe injections and from an infected mother to her baby during childbirth. Hepatitis C is transmitted primarily through exposure to infected blood.

There is, however, considerable reason for optimism.

An effective vaccine is available against Hepatitis B, making vaccination one of the most important tools for preventing infection. People already living with chronic Hepatitis B can also benefit from medical monitoring and, where indicated, antiviral treatment to reduce the risk of serious liver complications.

Although there is currently no vaccine against Hepatitis C, modern direct-acting antiviral medicines can cure more than 95 per cent of infections in many patient groups.

Ghana's response therefore needs to focus not only on treating those already infected but also on identifying the many people who may be carrying the viruses without knowing it.

The Ministry of Health and its agencies have been strengthening national efforts through hepatitis prevention and control initiatives, including expanded screening, surveillance, public education and integration with other health programmes.

These interventions will be critical if Ghana is to make meaningful progress towards the global 2030 elimination target.

Greater attention must also be given to pregnant women. Screening expectant mothers for Hepatitis B, appropriately managing women with high viral loads and ensuring timely vaccination of exposed newborns can substantially reduce mother-to-child transmission.

At the community level, education remains equally important. Misconceptions surrounding hepatitis can lead people to delay medical treatment or depend entirely on unproven remedies. Public education must therefore explain clearly how the viruses are transmitted, how they can be prevented and why early diagnosis matters.

The country also needs affordable and accessible testing. It is difficult to eliminate a disease when large numbers of infected people do not know their status.

Government, healthcare professionals, traditional and religious leaders, civil society organisations, employers and the media all have roles to play in encouraging voluntary testing and combating stigma.

Ghana's national hepatitis control structures provide an important foundation, but achieving elimination will require sustained financing, reliable data, accessible medicines, vaccination, early diagnosis and stronger healthcare services across the country.

For individuals, the message is straightforward: know your hepatitis status, get vaccinated against Hepatitis B if eligible and unprotected, avoid exposure to infected blood, and seek qualified medical care when diagnosed.

Viral hepatitis is preventable, manageable and, in the case of Hepatitis C, often curable. Ghana therefore has an opportunity to turn what has long been a silent public health threat into a disease that can be progressively brought under control.

The 2030 deadline is approaching. The challenge now is to ensure that prevention, testing and treatment reach every Ghanaian who needs them — regardless of where they live or their economic circumstances.

   Comments0